VMI

VHCP Management III Portfolio holdings

AUM $504M
This Quarter Return
+61.32%
1 Year Return
+678.37%
3 Year Return
5 Year Return
10 Year Return
AUM
$172M
AUM Growth
+$172M
Cap. Flow
+$6.59M
Cap. Flow %
3.84%
Top 10 Hldgs %
92.24%
Holding
17
New
2
Increased
2
Reduced
4
Closed
1
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
KALV icon
1
KalVista Pharmaceuticals
KALV
$678M
$27.8M 16.19%
970,630
-314,301
-24% -$9M
TCDA
2
DELISTED
Tricida, Inc. Common Stock
TCDA
$25.1M 14.65%
650,585
BCRX icon
3
BioCryst Pharmaceuticals
BCRX
$1.74B
$24.9M 14.53%
3,061,091
AXSM icon
4
Axsome Therapeutics
AXSM
$6.05B
$15.2M 8.86%
+1,068,044
New +$15.2M
OBSV
5
DELISTED
ObsEva SA Ordinary Shares
OBSV
$14.8M 8.65%
1,159,789
ORTX
6
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$14.5M 8.45%
811,030
-230,485
-22% -$4.12M
RARX
7
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$13.3M 7.77%
594,713
PTGX icon
8
Protagonist Therapeutics
PTGX
$3.67B
$10.2M 5.93%
809,323
+386,147
+91% +$4.85M
LJPC
9
DELISTED
La Jolla Pharmaceutical Company
LJPC
$6.45M 3.76%
+1,003,600
New +$6.45M
KNSA icon
10
Kiniksa Pharmaceuticals
KNSA
$2.48B
$5.92M 3.45%
327,777
MRNS
11
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$5.26M 3.07%
1,258,964
KDMN
12
DELISTED
Kadmon Holdings, Inc.
KDMN
$3.66M 2.14%
1,387,874
-1,000,698
-42% -$2.64M
BLPH
13
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
$1.58M 0.92%
2,417,227
+142,857
+6% +$93.3K
MTVA
14
MetaVia Inc. Common Stock
MTVA
$15.3M
$1M 0.58%
869,538
KA
15
DELISTED
Kineta, Inc. Common Stock
KA
$911K 0.53%
722,890
-125,720
-15% -$158K
CNST
16
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$903K 0.53%
66,667
DBVT
17
DBV Technologies
DBVT
$264M
-636,800
Closed -$4.09M